Associated Press103d agoneutral
Johnson & Johnson proposes $5.5 billion talc settlement to end marathon legal fightNews
High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.
106last 24h
3125last 7d
511● bullish (7d)
311● bearish (7d)
227publishers
The Wall Street Journal104d agobearish
Johnson & Johnson Agrees to Pay Up to $5.5 Billion to Settle Talc LawsuitsStocktwits104d agoneutral
JNJ Stock Advances After Hours On $5.5B Proposal To Resolve Talc LitigationInsider Monkey104d agoneutral
Johnson & Johnson (JNJ) Raised Its Outlook. Is It the Better Healthcare Stock to Own After Earnings?24/7 Wall St.104d agoneutral
Forget Social Security: 5 Sleep-at-Night Dividend Stocks Retirees Are Using to Replace a PaycheckBenzinga107d agobullish
FDA Approves Johnson & Johnson Table-Integrated OTTAVA Robotic Surgery System24/7 Wall St.107d agoneutral
3 Dividend Stocks Baby Boomers Should Own for the Rest of Their LivesThe Daily Upside109d agoneutral
Trump’s 100% Tariffs on Generic Meds Threaten Headaches at Drugstore CheckoutsReuters109d agobullish
J&J enters US robotic surgery market after device gets marketing authorizationMotley Fool112d agobullish
Is It Too Late to Buy Johnson & Johnson After Its Blowout Earnings Report?